HP184 in Chronic Spinal Cord Injury Subjects
NCT00093275
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
262
Enrollment
INDUSTRY
Sponsor class
Conditions
Spinal Cord Injury
Interventions
DRUG:
HP184
Sponsor
Sanofi